Market Overview
The global beta glucan market size reached USD 547.6 Million in 2024, and it is expected to grow to USD 957.4 Million by 2033. This represents a CAGR of 6.4% during the forecast period 2025-2033. The growth is driven mainly by the increasing use of beta-glucan in functional foods and fortified beverages, alongside rising consumer awareness of healthy lifestyle benefits.
Study Assumption Years
- Base Year: 2024
- Historical Year/Period: 2019-2024
- Forecast Year/Period: 2025-2033
Beta-Glucan Market Key Takeaways
- The global beta glucan market size was USD 547.6 Million in 2024, and it is projected to reach USD 957.4 Million by 2033 with a CAGR of 6.4% during 2025-2033.
- The escalating demand for natural immunity boosters to combat lifestyle diseases is bolstering the market.
- Europe exhibits clear market dominance due to widespread adoption of beta-glucan products aiding cholesterol reduction and immune support.
- The yeast source segment holds the largest market share owing to its skin-soothing benefits and high purity.
- Soluble beta-glucan dominates the type segment due to its immune-boosting properties and incorporation in functional foods and supplements.
- Beta-glucans are gaining traction in the personal care industry for their anti-inflammatory and skin-soothing effects.
Sample Request Link:
https://www.imarcgroup.com/beta-glucan-market/requestsample
Market Growth Factors
The growing use of beta-glucan in functional foods and fortified drinks, along with a surge in consumer awareness about healthy living, is really driving the market forward. Beta-glucan is becoming known as a natural immunity booster, especially as lifestyle-related diseases like diabetes and heart issues continue to rise. More and more people are turning to beta-glucan for its benefits in modulating immunity and lowering cholesterol. Regulatory agencies like the European Food Safety Authority (EFSA) and the U.S. Food and Drug Administration (FDA) have acknowledged that oat beta-glucan can help reduce blood cholesterol levels and lower the risk of heart disease, which is fueling demand in the market.
In the personal care and cosmetics industry, beta-glucan is gaining traction thanks to its skin-soothing and anti-inflammatory qualities. Consumers are increasingly favoring beta-glucan over traditional ingredients like hyaluronic acid because of its superior healing properties and its ability to enhance skin hydration and softness. This trend is leading to its greater inclusion in skincare products.
Market Segmentation
By Type:
- Soluble: Soluble beta-glucan accounts for the largest market share due to its immune-boosting properties and easier incorporation into functional foods, beverages, and dietary supplements.
- Insoluble: Included as a market segment but less dominant.
By Source:
- Cereal: Part of the market segmentation.
- Mushroom: Covered in the report.
- Yeasts: Yeast-derived beta-glucan is the largest segment, preferred for its high purity and skin-soothing benefits, along with growing clinical trial investments.
- Seaweed: Included as a source segment.
By Industry Vertical:
- Animal Feed: Beta-glucan is valued for its immunomodulatory and gut health benefits, with regulatory considerations ensuring safety and efficacy.
- Personal Care and Cosmetics: Beta-glucan is used in products targeting skin conditions such as eczema and premature aging, with ingredients like BASF's Hydrasensyl Glucan soothing and moisturizing the skin.
- Pharmaceuticals: Utilized as an adjunct in treatment of various conditions.
- Others: Includes eco-friendly paper packaging applications replacing petroleum plastics.
Regional Insights
Europe dominates the global beta glucan market, attributable to high consumer adoption to lower cholesterol and strengthen immunity. The presence of regulatory frameworks like EFSA validates health claims, encouraging market growth. For instance, Kemin Industries received EFSA's positive opinion for BetaVia Pure algae-based postbiotic in 2023. Europe’s tailored marketing strategies and regulatory compliance further support its leadership position.
Recent Developments & News
- April 2024: Kemin Industries received European Commission novel food authorization for BetaVia Pure containing 95% beta 1,3 glucan.
- March 2024: Solabia-BioActor obtained U.S. FDA approval for Generally Recognized as Safe (GRAS) status for their women’s health ingredient Bonolive.
- August 2023: Immudyne Nutritional developed PureMune, a beta-glucan ingredient produced in an FDA-registered facility.
Key Players
- Biorigin
- COSCIENS Biopharma Inc
- Garuda International, Inc
- Givaudan
- Kemin Industries, Inc
- Kerry Group plc
- Lallemand Inc
- Lantmännnen Biorefineries
- Lesaffre
- Super Beta Glucan
- VW-Ingredients
Customization Note:
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
Request For Customization:
https://www.imarcgroup.com/request?type=report&id=4818&flag=E
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: (D) +91 120 433 0800
United States: +1-201971-6302
Comments (0)